BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20471224)

  • 1. Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.
    Sevy S; Robinson DG; Napolitano B; Patel RC; Gunduz-Bruce H; Miller R; McCormack J; Lorell BS; Kane J
    Schizophr Res; 2010 Jul; 120(1-3):101-7. PubMed ID: 20471224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
    Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
    Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.
    Sevy S; Robinson DG; Sunday S; Napolitano B; Miller R; McCormack J; Kane J
    Psychiatry Res; 2011 Aug; 188(3):310-4. PubMed ID: 21636134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use disorders in schizophrenia: effects on cognition and symptoms.
    DeRosse P; Kaplan A; Burdick KE; Lencz T; Malhotra AK
    Schizophr Res; 2010 Jul; 120(1-3):95-100. PubMed ID: 20483565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
    Rodríguez-Sánchez JM; Ayesa-Arriola R; Mata I; Moreno-Calle T; Perez-Iglesias R; González-Blanch C; Periañez JA; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Dec; 124(1-3):142-51. PubMed ID: 20826079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
    Crespo-Facorro B; Pelayo-Terán JM; Pérez-Iglesias R; Ramírez-Bonilla M; Martínez-García O; Pardo-García G; Vázquez-Barquero JL
    J Psychiatr Res; 2007 Oct; 41(8):659-66. PubMed ID: 16797591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive attention impairment in adolescents with schizophrenia who have used cannabis.
    Epstein KA; Kumra S
    Schizophr Res; 2014 Aug; 157(1-3):48-54. PubMed ID: 24875171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia.
    Brousse G; Meary A; Blanc O; Lançon C; Llorca PM; Leboyer M
    Psychiatry Res; 2010 Aug; 179(1):12-8. PubMed ID: 20472305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
    J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive evaluation of adverse childhood experiences, social-emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practice.
    Trovini G; Amici E; Bauco P; Matrone M; Lombardozzi G; Giovanetti V; Kotzalidis GD; De Filippis S
    Eur Psychiatry; 2023 Sep; 66(1):e77. PubMed ID: 37702087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of age at first alcohol and nicotine use for initiation of cannabis use and progression to cannabis use disorders.
    Behrendt S; Beesdo-Baum K; Höfler M; Perkonigg A; Bühringer G; Lieb R; Wittchen HU
    Drug Alcohol Depend; 2012 Jun; 123(1-3):48-56. PubMed ID: 22071122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use disorder and age at onset of psychosis--a study in first-episode patients.
    Schimmelmann BG; Conus P; Cotton SM; Kupferschmid S; Karow A; Schultze-Lutter F; McGorry PD; Lambert M
    Schizophr Res; 2011 Jun; 129(1):52-6. PubMed ID: 21498049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.
    Pelayo-Terán JM; Diaz FJ; Pérez-Iglesias R; Suárez-Pinilla P; Tabarés-Seisdedos R; de León J; Crespo-Facorro B
    Psychol Med; 2014 Jan; 44(1):37-50. PubMed ID: 23461899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A rare and not very studied disorder: childhood-onset schizophrenia. A case report].
    Bailly D; de Chouly de Lenclave MB
    Encephale; 2004; 30(6):540-7. PubMed ID: 15738856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.
    Pauselli L; Birnbaum ML; Vázquez Jaime BP; Paolini E; Kelley ME; Broussard B; Compton MT
    Schizophr Res; 2018 Jul; 197():544-549. PubMed ID: 29397281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.
    Coulston CM; Perdices M; Tennant CC
    Schizophr Res; 2007 Nov; 96(1-3):169-84. PubMed ID: 17826035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia.
    Goldberg TE; Burdick KE; McCormack J; Napolitano B; Patel RC; Sevy SM; Goldman R; Lencz T; Malhotra AK; Kane JM; Robinson DG
    Schizophr Res; 2009 Feb; 107(2-3):262-6. PubMed ID: 19042105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study.
    Machielsen MW; Veltman DJ; van den Brink W; de Haan L
    J Psychopharmacol; 2014 Jul; 28(7):633-42. PubMed ID: 24646809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.